{"hands_on_practices": [{"introduction": "A key neurophysiological distinction between acute and chronic pain lies in the brain's own pain-regulating systems. This practice delves into Conditioned Pain Modulation (CPM), a \"pain inhibits pain\" phenomenon that reflects the efficacy of descending inhibitory pathways. By calculating and comparing the CPM effect from hypothetical data, you will operationalize how this crucial endogenous analgesia system can be impaired in chronic pain conditions [@problem_id:4708771].", "problem": "A psychophysical study examines Conditioned Pain Modulation (CPM) in two groups: individuals experiencing experimentally induced acute pain (healthy volunteers; group $\\text{A}$) and individuals with clinically diagnosed chronic low back pain (group $\\text{C}$). Each participant rated perceived pain intensity of a standardized test stimulus on a numeric rating scale from $0$ to $100$ at two time points: once at baseline (no conditioning stimulus) and once while concurrently experiencing a separate conditioning painful stimulus. Conditioned Pain Modulation (CPM) is defined as the reduction in perceived pain under conditioning and operationalized as $\\text{CPM}=\\text{baseline}-\\text{conditioned}$. Positive values of $\\text{CPM}$ indicate engagement of descending inhibitory control.\n\nYou are provided the baseline and conditioned ratings for $5$ participants per group. All values are in rating points on the $0$ to $100$ scale.\n\n- Group $\\text{A}$ (acute): \n  - $\\text{A1}$: baseline $62$, conditioned $43$\n  - $\\text{A2}$: baseline $58$, conditioned $46$\n  - $\\text{A3}$: baseline $65$, conditioned $50$\n  - $\\text{A4}$: baseline $60$, conditioned $47$\n  - $\\text{A5}$: baseline $64$, conditioned $48$\n\n- Group $\\text{C}$ (chronic): \n  - $\\text{C1}$: baseline $63$, conditioned $58$\n  - $\\text{C2}$: baseline $61$, conditioned $57$\n  - $\\text{C3}$: baseline $59$, conditioned $56$\n  - $\\text{C4}$: baseline $66$, conditioned $62$\n  - $\\text{C5}$: baseline $60$, conditioned $58$\n\nUsing only the definition of $\\text{CPM}$ and the interpretation that lower $\\text{CPM}$ reflects impaired descending inhibitory circuitry, compute the between-group CPM difference defined as\n$$\n\\Delta_{\\text{CPM}}=\\overline{\\text{CPM}}_{\\text{A}}-\\overline{\\text{CPM}}_{\\text{C}},\n$$\nwhere $\\overline{\\text{CPM}}_{\\text{A}}$ and $\\overline{\\text{CPM}}_{\\text{C}}$ denote the arithmetic mean CPM across participants in groups $\\text{A}$ and $\\text{C}$, respectively. Report the final value of $\\Delta_{\\text{CPM}}$ in rating points, rounded to four significant figures. Your final answer must be a single real number.", "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded in the principles of psychophysics and pain research, specifically the Conditioned Pain Modulation (CPM) paradigm. The problem is well-posed, providing all necessary data and a clear, unambiguous operational definition for the quantity to be calculated. The language is objective and the data are complete and consistent.\n\nThe objective is to compute the between-group difference in Conditioned Pain Modulation, defined as $\\Delta_{\\text{CPM}}=\\overline{\\text{CPM}}_{\\text{A}}-\\overline{\\text{CPM}}_{\\text{C}}$. This requires a three-step calculation:\n$1$. Compute the CPM score for each participant in both groups.\n$2$. Compute the arithmetic mean of the CPM scores for each group ($\\overline{\\text{CPM}}_{\\text{A}}$ and $\\overline{\\text{CPM}}_{\\text{C}}$).\n$3$. Compute the difference between the two group means.\n\nThe definition of CPM for a single participant is given as $\\text{CPM}=\\text{baseline}-\\text{conditioned}$.\n\nFirst, we calculate the CPM score for each of the $n_{\\text{A}}=5$ participants in group $\\text{A}$ (acute pain). Let $\\text{CPM}_{\\text{A},i}$ denote the CPM score for the $i$-th participant in group $\\text{A}$.\n- For participant $\\text{A1}$: $\\text{CPM}_{\\text{A},1} = 62 - 43 = 19$.\n- For participant $\\text{A2}$: $\\text{CPM}_{\\text{A},2} = 58 - 46 = 12$.\n- For participant $\\text{A3}$: $\\text{CPM}_{\\text{A},3} = 65 - 50 = 15$.\n- For participant $\\text{A4}$: $\\text{CPM}_{\\text{A},4} = 60 - 47 = 13$.\n- For participant $\\text{A5}$: $\\text{CPM}_{\\text{A},5} = 64 - 48 = 16$.\n\nNext, we compute the arithmetic mean of these scores for group $\\text{A}$, $\\overline{\\text{CPM}}_{\\text{A}}$.\n$$\n\\overline{\\text{CPM}}_{\\text{A}} = \\frac{1}{n_{\\text{A}}} \\sum_{i=1}^{n_{\\text{A}}} \\text{CPM}_{\\text{A},i} = \\frac{19 + 12 + 15 + 13 + 16}{5}\n$$\nThe sum of the scores is $19 + 12 + 15 + 13 + 16 = 75$.\n$$\n\\overline{\\text{CPM}}_{\\text{A}} = \\frac{75}{5} = 15\n$$\n\nSecond, we repeat the process for the $n_{\\text{C}}=5$ participants in group $\\text{C}$ (chronic pain). Let $\\text{CPM}_{\\text{C},i}$ denote the CPM score for the $i$-th participant in group $\\text{C}$.\n- For participant $\\text{C1}$: $\\text{CPM}_{\\text{C},1} = 63 - 58 = 5$.\n- For participant $\\text{C2}$: $\\text{CPM}_{\\text{C},2} = 61 - 57 = 4$.\n- For participant $\\text{C3}$: $\\text{CPM}_{\\text{C},3} = 59 - 56 = 3$.\n- For participant $\\text{C4}$: $\\text{CPM}_{\\text{C},4} = 66 - 62 = 4$.\n- For participant $\\text{C5}$: $\\text{CPM}_{\\text{C},5} = 60 - 58 = 2$.\n\nNext, we compute the arithmetic mean of these scores for group $\\text{C}$, $\\overline{\\text{CPM}}_{\\text{C}}$.\n$$\n\\overline{\\text{CPM}}_{\\text{C}} = \\frac{1}{n_{\\text{C}}} \\sum_{i=1}^{n_{\\text{C}}} \\text{CPM}_{\\text{C},i} = \\frac{5 + 4 + 3 + 4 + 2}{5}\n$$\nThe sum of the scores is $5 + 4 + 3 + 4 + 2 = 18$.\n$$\n\\overline{\\text{CPM}}_{\\text{C}} = \\frac{18}{5} = 3.6\n$$\n\nFinally, we compute the between-group CPM difference, $\\Delta_{\\text{CPM}}$, by subtracting the mean of group $\\text{C}$ from the mean of group $\\text{A}$.\n$$\n\\Delta_{\\text{CPM}} = \\overline{\\text{CPM}}_{\\text{A}} - \\overline{\\text{CPM}}_{\\text{C}} = 15 - 3.6 = 11.4\n$$\nThe problem requires the final value to be rounded to four significant figures. The calculated value $11.4$ has three significant figures. To express this with four significant figures, we add a trailing zero, resulting in $11.40$. The interpretation, consistent with the problem statement, is that the chronic pain group exhibits a substantially lower CPM effect, suggesting impaired descending inhibitory control compared to the healthy acute pain group.", "answer": "$$\\boxed{11.40}$$", "id": "4708771"}, {"introduction": "Cognitive Behavioral Therapy (CBT) is a cornerstone of psychological treatment for pain, with graded exposure being a key technique to overcome fear and avoidance. However, clinical experience suggests that progress can differ between acute and chronic pain sufferers. This exercise allows you to model and quantify how factors like treatment adherence and learning sensitivity can lead to different therapeutic outcomes, providing a quantitative perspective on the challenges of treating chronic pain [@problem_id:4708685].", "problem": "A cohort of patients with acute pain and a cohort with chronic pain each undergo a graded exposure intervention within Cognitive Behavioral Therapy (CBT). Let the internal fear state be represented by a scalar $F_t$ measured in arbitrary units (a.u.) at session $t$. Assume the following context-appropriate base: in exposure-based learning, the incremental change in fear within a session is proportional to the dose of exposure actually performed, with a cohort-specific sensitivity parameter (learning rate) $\\eta$, such that greater performed exposure yields larger reduction in $F_t$.\n\nBoth cohorts have the same scheduled graded exposure doses over $T=6$ sessions: for session $t \\in \\{1,2,3,4,5,6\\}$, the scheduled dose is $e_t=\\frac{t}{10}$ a.u. Due to avoidance and pain-related barriers, the probability that a scheduled exposure is actually completed in a session differs by cohort. For the acute pain cohort, the completion probability is $p_a=\\frac{3}{4}$ and the sensitivity parameter is $\\eta_a=\\frac{1}{4}$. For the chronic pain cohort, the completion probability is $p_c=\\frac{1}{2}$ and the sensitivity parameter is $\\eta_c=\\frac{1}{6}$. Assume independence of completion events across sessions, no spontaneous recovery, and no cross-session generalization other than accumulation of learning. Both cohorts start with the same initial fear $F_0=1$ a.u.\n\nUsing only the stated base (proportional change with sensitivity parameter) and the given parameters, compute the expected total reduction in fear over $T=6$ sessions in each cohort and then report a single number: the ratio of the acute cohort’s expected total reduction to the chronic cohort’s expected total reduction. Express the final ratio as an exact value. No rounding is required. The ratio is dimensionless; do not include units in the final boxed answer.", "solution": "The problem requires the calculation of the ratio of the expected total reduction in fear for an acute pain cohort to that of a chronic pain cohort. Let the total fear reduction for the acute cohort be $R_a$ and for the chronic cohort be $R_c$. We are asked to find the ratio $\\frac{E[R_a]}{E[R_c]}$.\n\nAccording to the problem statement, the incremental change in fear, $\\Delta F_t$, in a session $t$ is proportional to the dose of exposure actually performed. Let $D_t$ be the random variable representing the dose performed in session $t$. The statement \"greater performed exposure yields larger reduction in $F_t$\" implies that the change is a decrease. The proportionality constant is the sensitivity parameter $\\eta$. Thus, the change in fear in session $t$ is:\n$$ \\Delta F_t = -\\eta D_t $$\nThe reduction in fear in session $t$ is the positive value $-\\Delta F_t = \\eta D_t$. The total reduction over $T$ sessions is the sum of the reductions in each session:\n$$ R = \\sum_{t=1}^{T} \\eta D_t $$\nWe are interested in the expected total reduction, $E[R]$. By the linearity of expectation:\n$$ E[R] = E\\left[\\sum_{t=1}^{T} \\eta D_t\\right] = \\eta \\sum_{t=1}^{T} E[D_t] $$\nThe dose performed in session $t$, $D_t$, is a random variable. The scheduled dose is $e_t$. This dose is completed with probability $p$, and not completed (i.e., dose is $0$) with probability $1-p$. The expected value of $D_t$ is therefore:\n$$ E[D_t] = e_t \\cdot p + 0 \\cdot (1-p) = p \\cdot e_t $$\nSubstituting this back into the expression for the expected total reduction gives:\n$$ E[R] = \\eta \\sum_{t=1}^{T} (p \\cdot e_t) = \\eta p \\sum_{t=1}^{T} e_t $$\nThis general formula can now be applied to each cohort.\n\nFirst, let's calculate the sum of the scheduled doses over the $T=6$ sessions. The scheduled dose for session $t$ is $e_t = \\frac{t}{10}$.\n$$ \\sum_{t=1}^{6} e_t = \\sum_{t=1}^{6} \\frac{t}{10} = \\frac{1}{10} \\sum_{t=1}^{6} t $$\nThe sum of the first $n$ integers is given by the formula $\\frac{n(n+1)}{2}$. For $n=6$:\n$$ \\sum_{t=1}^{6} t = \\frac{6(6+1)}{2} = \\frac{6 \\times 7}{2} = 21 $$\nSo, the total scheduled dose is:\n$$ \\sum_{t=1}^{6} e_t = \\frac{21}{10} $$\n\nNow, we calculate the expected total reduction for the acute pain cohort, $E[R_a]$. The parameters are $\\eta_a = \\frac{1}{4}$ and $p_a = \\frac{3}{4}$.\n$$ E[R_a] = \\eta_a p_a \\sum_{t=1}^{6} e_t = \\left(\\frac{1}{4}\\right) \\left(\\frac{3}{4}\\right) \\left(\\frac{21}{10}\\right) = \\frac{3 \\times 21}{4 \\times 4 \\times 10} = \\frac{63}{160} $$\n\nNext, we calculate the expected total reduction for the chronic pain cohort, $E[R_c]$. The parameters are $\\eta_c = \\frac{1}{6}$ and $p_c = \\frac{1}{2}$.\n$$ E[R_c] = \\eta_c p_c \\sum_{t=1}^{6} e_t = \\left(\\frac{1}{6}\\right) \\left(\\frac{1}{2}\\right) \\left(\\frac{21}{10}\\right) = \\frac{1 \\times 21}{6 \\times 2 \\times 10} = \\frac{21}{120} $$\nThis fraction can be simplified by dividing the numerator and denominator by their greatest common divisor, which is $3$:\n$$ E[R_c] = \\frac{21 \\div 3}{120 \\div 3} = \\frac{7}{40} $$\n\nFinally, we compute the required ratio of the acute cohort's expected total reduction to the chronic cohort's expected total reduction.\n$$ \\frac{E[R_a]}{E[R_c]} = \\frac{\\frac{63}{160}}{\\frac{7}{40}} = \\frac{63}{160} \\times \\frac{40}{7} $$\nWe can simplify this expression before multiplying:\n$$ \\frac{E[R_a]}{E[R_c]} = \\frac{63}{7} \\times \\frac{40}{160} = 9 \\times \\frac{1}{4} = \\frac{9}{4} $$\nThe initial fear state $F_0=1$ was not required for this calculation, as the question asks for the reduction in fear, not the final fear level.", "answer": "$$\\boxed{\\frac{9}{4}}$$", "id": "4708685"}, {"introduction": "Why do some individuals with acute pain recover while others develop a chronic condition? This question is central to pain research and prevention. This practice introduces you to survival analysis, a powerful epidemiological tool used to model the transition from acute to chronic pain over time. By deriving hazard functions, you will see how psychological risk factors like pain catastrophizing can be mathematically incorporated to quantify an individual's moment-to-moment risk of \"chronification\" [@problem_id:4708738].", "problem": "In medical psychology, the transition from acute to chronic pain can be represented as a time-to-event process, where the event is defined as crossing from an acute state to a chronic state (for example, clinical persistence of pain beyond $12$ weeks). Let $T$ denote the random time at which an individual transitions to chronic pain, and let the survival function be $S(t) = \\Pr(T > t)$, representing the probability that the individual remains in the acute state at time $t$. The hazard function $h(t)$ is the instantaneous rate of transition at time $t$ conditional on not yet having transitioned at time $t$, and is formally defined by $h(t) = -\\frac{d}{dt}\\ln S(t)$.\n\nAssume that biopsychosocial processes governing early inflammatory responses and later recovery yield a unimodal baseline hazard of the form $h_{0}(t) = \\alpha\\, t\\, \\exp(-\\gamma t)$ with $\\alpha > 0$ and $\\gamma > 0$, which captures elevated early risk followed by decline. Assume further that psychological and behavioral risk factors act multiplicatively on the instantaneous risk via a log-linear mapping (the Cox Proportional Hazards model (CPH)), where the covariates are standardized Pain Catastrophizing ($x_{C}$), standardized Depressive Symptoms ($x_{D}$), and Opioid Exposure indicator ($x_{O} \\in \\{0,1\\}$), with coefficients $\\beta_{C}$, $\\beta_{D}$, and $\\beta_{O}$, respectively.\n\nLet time $t$ be measured in weeks and hazard be expressed in per-week units. Use the following parameter values: $\\alpha = 0.18$, $\\gamma = 0.30$, $\\beta_{C} = 0.60$, $\\beta_{D} = 0.40$, and $\\beta_{O} = 0.80$.\n\nDerive, from first principles starting with the definition of $h(t)$ and the survival function, the explicit hazard functions $h_{A}(t)$, $h_{B}(t)$, and $h_{C}(t)$ under the CPH assumption for the following three risk profiles:\n- Profile A (resilient): $x_{C} = 0$, $x_{D} = 0$, $x_{O} = 0$,\n- Profile B (high catastrophizing, moderate depression, opioid exposure): $x_{C} = 1.5$, $x_{D} = 1.0$, $x_{O} = 1$,\n- Profile C (moderate catastrophizing, high depression, no opioid exposure): $x_{C} = 0.5$, $x_{D} = 2.0$, $x_{O} = 0$.\n\nExpress your final answer as a single row matrix containing the three hazard functions, each as a closed-form analytic expression in $t$. No rounding is required. State the hazards in per-week units, but do not include units in the final boxed expressions.", "solution": "The problem statement includes the fundamental definition of the hazard function, $h(t) = - \\frac{d}{dt} \\ln S(t)$, where $S(t)$ is the survival function. However, the solution proceeds directly from the structure of the CPH model, which provides a specific form for $h(t)$. The CPH model posits that the hazard function for an individual with a vector of covariates $\\mathbf{x}$ is proportional to a baseline hazard function $h_0(t)$. The relationship is given by:\n$$h(t; \\mathbf{x}) = h_0(t) \\exp(\\boldsymbol{\\beta}^T \\mathbf{x})$$\nwhere $\\boldsymbol{\\beta}$ is a vector of coefficients corresponding to the covariates.\n\nIn this problem, the covariates are Pain Catastrophizing ($x_{C}$), Depressive Symptoms ($x_{D}$), and Opioid Exposure ($x_{O}$). The hazard function is thus:\n$$h(t) = h_0(t) \\exp(\\beta_{C} x_{C} + \\beta_{D} x_{D} + \\beta_{O} x_{O})$$\nThe term $\\exp(\\beta_{C} x_{C} + \\beta_{D} x_{D} + \\beta_{O} x_{O})$ is the hazard ratio (HR), a constant multiplier that scales the baseline hazard according to the individual's risk factor profile.\n\nThe baseline hazard function is given as:\n$$h_{0}(t) = \\alpha t \\exp(-\\gamma t)$$\nCombining these gives the full hazard model for a given set of covariates:\n$$h(t) = \\left( \\alpha t \\exp(-\\gamma t) \\right) \\exp(\\beta_{C} x_{C} + \\beta_{D} x_{D} + \\beta_{O} x_{O})$$\nThis can be rearranged to a more convenient form:\n$$h(t) = \\alpha \\exp(\\beta_{C} x_{C} + \\beta_{D} x_{D} + \\beta_{O} x_{O}) \\, t \\exp(-\\gamma t)$$\n\nThe problem provides the following parameter values, all in compatible units (time in weeks, hazard in per-week):\n$\\alpha = 0.18$\n$\\gamma = 0.30$\n$\\beta_{C} = 0.60$\n$\\beta_{D} = 0.40$\n$\\beta_{O} = 0.80$\n\nWe now derive the explicit hazard function for each of the three specified risk profiles by substituting the respective covariate values into the general model.\n\n**Profile A (resilient):**\nThe covariates for this profile are $x_{C} = 0$, $x_{D} = 0$, and $x_{O} = 0$.\nThe linear combination in the exponent, which represents the log-hazard ratio, is:\n$$\\beta_{C} x_{C} + \\beta_{D} x_{D} + \\beta_{O} x_{O} = (0.60)(0) + (0.40)(0) + (0.80)(0) = 0$$\nThe hazard ratio is $\\exp(0) = 1$.\nTherefore, the hazard function for Profile A, $h_{A}(t)$, is identical to the baseline hazard function:\n$$h_{A}(t) = h_{0}(t) = \\alpha t \\exp(-\\gamma t)$$\nSubstituting the given values for $\\alpha$ and $\\gamma$:\n$$h_{A}(t) = 0.18 t \\exp(-0.30 t)$$\n\n**Profile B (high catastrophizing, moderate depression, opioid exposure):**\nThe covariates for this profile are $x_{C} = 1.5$, $x_{D} = 1.0$, and $x_{O} = 1$.\nThe linear combination in the exponent is:\n$$\\beta_{C} x_{C} + \\beta_{D} x_{D} + \\beta_{O} x_{O} = (0.60)(1.5) + (0.40)(1.0) + (0.80)(1)$$\n$$= 0.90 + 0.40 + 0.80 = 2.10$$\nThe hazard ratio is $\\exp(2.10)$.\nThe hazard function for Profile B, $h_{B}(t)$, is the baseline hazard scaled by this factor:\n$$h_{B}(t) = h_{0}(t) \\exp(2.10) = (\\alpha t \\exp(-\\gamma t)) \\exp(2.10)$$\nSubstituting the values for $\\alpha$ and $\\gamma$ and arranging terms gives:\n$$h_{B}(t) = 0.18 \\exp(2.10) t \\exp(-0.30 t)$$\n\n**Profile C (moderate catastrophizing, high depression, no opioid exposure):**\nThe covariates for this profile are $x_{C} = 0.5$, $x_{D} = 2.0$, and $x_{O} = 0$.\nThe linear combination in the exponent is:\n$$\\beta_{C} x_{C} + \\beta_{D} x_{D} + \\beta_{O} x_{O} = (0.60)(0.5) + (0.40)(2.0) + (0.80)(0)$$\n$$= 0.30 + 0.80 + 0 = 1.10$$\nThe hazard ratio is $\\exp(1.10)$.\nThe hazard function for Profile C, $h_{C}(t)$, is the baseline hazard scaled by this factor:\n$$h_{C}(t) = h_{0}(t) \\exp(1.10) = (\\alpha t \\exp(-\\gamma t)) \\exp(1.10)$$\nSubstituting the values for $\\alpha$ and $\\gamma$ and arranging terms gives:\n$$h_{C}(t) = 0.18 \\exp(1.10) t \\exp(-0.30 t)$$\n\nThese three expressions provide the closed-form analytic solutions for the hazard functions corresponding to the specified risk profiles.", "answer": "$$\n\\boxed{\\begin{pmatrix} 0.18 t \\exp(-0.30 t) & 0.18 \\exp(2.10) t \\exp(-0.30 t) & 0.18 \\exp(1.10) t \\exp(-0.30 t) \\end{pmatrix}}\n$$", "id": "4708738"}]}